Growth failure as a prognostic indicator of mortality in pediatric HIV infection.

R. Berhane, D. Bagenda, L. Marum, E. Aceng, C. Ndugwa, R. J. Bosch, K. Olness

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

OBJECTIVE: To study the effect of perinatally acquired human immunodeficiency virus (HIV) on somatic growth and examine the relationship of nutritional status to mortality in HIV-infected infants. METHOD: Pregnant women attending the antenatal clinic at Mulago hospital in Kampala, Uganda, were enrolled. All live-born babies born to HIV-1 seropositive (HIV+) women, and to every fourth age-matched HIV-1 seronegative (HIV-) woman, were followed for 25 months. RESULTS: The mean weight-for-age and length-for-age curves of HIV+ children were significantly lower than those of HIV- controls and seroeverters. Forty-five (54%) of the 84 HIV+ infants died before their second birthday, as compared with a 1.6% and 5.6% mortality in HIV- and seroeverters. HIV+ infants with an average weight-for-age Z-score below -1.5 in the first year of life have a nearly fivefold risk of dying before 25 months of age compared with noninfected controls. CONCLUSION: Perinatally acquired HIV infection is associated with early and progressive growth failure. The severity of growth failure is associated with an increased risk of mortality. The effect of early, aggressive nutritional intervention in delaying HIV progression and mortality should be evaluated by controlled intervention studies.

Original languageEnglish (US)
Pages (from-to)E7
JournalPediatrics
Volume100
Issue number1
StatePublished - Jul 1997

Fingerprint

Virus Diseases
HIV
Pediatrics
Mortality
Growth
HIV-1
Weights and Measures
Uganda
Nutritional Status
Pregnant Women

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Berhane, R., Bagenda, D., Marum, L., Aceng, E., Ndugwa, C., Bosch, R. J., & Olness, K. (1997). Growth failure as a prognostic indicator of mortality in pediatric HIV infection. Pediatrics, 100(1), E7.

Growth failure as a prognostic indicator of mortality in pediatric HIV infection. / Berhane, R.; Bagenda, D.; Marum, L.; Aceng, E.; Ndugwa, C.; Bosch, R. J.; Olness, K.

In: Pediatrics, Vol. 100, No. 1, 07.1997, p. E7.

Research output: Contribution to journalArticle

Berhane, R, Bagenda, D, Marum, L, Aceng, E, Ndugwa, C, Bosch, RJ & Olness, K 1997, 'Growth failure as a prognostic indicator of mortality in pediatric HIV infection.', Pediatrics, vol. 100, no. 1, pp. E7.
Berhane R, Bagenda D, Marum L, Aceng E, Ndugwa C, Bosch RJ et al. Growth failure as a prognostic indicator of mortality in pediatric HIV infection. Pediatrics. 1997 Jul;100(1):E7.
Berhane, R. ; Bagenda, D. ; Marum, L. ; Aceng, E. ; Ndugwa, C. ; Bosch, R. J. ; Olness, K. / Growth failure as a prognostic indicator of mortality in pediatric HIV infection. In: Pediatrics. 1997 ; Vol. 100, No. 1. pp. E7.
@article{c8aa609b3c97452688b039ccf1e337d4,
title = "Growth failure as a prognostic indicator of mortality in pediatric HIV infection.",
abstract = "OBJECTIVE: To study the effect of perinatally acquired human immunodeficiency virus (HIV) on somatic growth and examine the relationship of nutritional status to mortality in HIV-infected infants. METHOD: Pregnant women attending the antenatal clinic at Mulago hospital in Kampala, Uganda, were enrolled. All live-born babies born to HIV-1 seropositive (HIV+) women, and to every fourth age-matched HIV-1 seronegative (HIV-) woman, were followed for 25 months. RESULTS: The mean weight-for-age and length-for-age curves of HIV+ children were significantly lower than those of HIV- controls and seroeverters. Forty-five (54{\%}) of the 84 HIV+ infants died before their second birthday, as compared with a 1.6{\%} and 5.6{\%} mortality in HIV- and seroeverters. HIV+ infants with an average weight-for-age Z-score below -1.5 in the first year of life have a nearly fivefold risk of dying before 25 months of age compared with noninfected controls. CONCLUSION: Perinatally acquired HIV infection is associated with early and progressive growth failure. The severity of growth failure is associated with an increased risk of mortality. The effect of early, aggressive nutritional intervention in delaying HIV progression and mortality should be evaluated by controlled intervention studies.",
author = "R. Berhane and D. Bagenda and L. Marum and E. Aceng and C. Ndugwa and Bosch, {R. J.} and K. Olness",
year = "1997",
month = "7",
language = "English (US)",
volume = "100",
pages = "E7",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1",

}

TY - JOUR

T1 - Growth failure as a prognostic indicator of mortality in pediatric HIV infection.

AU - Berhane, R.

AU - Bagenda, D.

AU - Marum, L.

AU - Aceng, E.

AU - Ndugwa, C.

AU - Bosch, R. J.

AU - Olness, K.

PY - 1997/7

Y1 - 1997/7

N2 - OBJECTIVE: To study the effect of perinatally acquired human immunodeficiency virus (HIV) on somatic growth and examine the relationship of nutritional status to mortality in HIV-infected infants. METHOD: Pregnant women attending the antenatal clinic at Mulago hospital in Kampala, Uganda, were enrolled. All live-born babies born to HIV-1 seropositive (HIV+) women, and to every fourth age-matched HIV-1 seronegative (HIV-) woman, were followed for 25 months. RESULTS: The mean weight-for-age and length-for-age curves of HIV+ children were significantly lower than those of HIV- controls and seroeverters. Forty-five (54%) of the 84 HIV+ infants died before their second birthday, as compared with a 1.6% and 5.6% mortality in HIV- and seroeverters. HIV+ infants with an average weight-for-age Z-score below -1.5 in the first year of life have a nearly fivefold risk of dying before 25 months of age compared with noninfected controls. CONCLUSION: Perinatally acquired HIV infection is associated with early and progressive growth failure. The severity of growth failure is associated with an increased risk of mortality. The effect of early, aggressive nutritional intervention in delaying HIV progression and mortality should be evaluated by controlled intervention studies.

AB - OBJECTIVE: To study the effect of perinatally acquired human immunodeficiency virus (HIV) on somatic growth and examine the relationship of nutritional status to mortality in HIV-infected infants. METHOD: Pregnant women attending the antenatal clinic at Mulago hospital in Kampala, Uganda, were enrolled. All live-born babies born to HIV-1 seropositive (HIV+) women, and to every fourth age-matched HIV-1 seronegative (HIV-) woman, were followed for 25 months. RESULTS: The mean weight-for-age and length-for-age curves of HIV+ children were significantly lower than those of HIV- controls and seroeverters. Forty-five (54%) of the 84 HIV+ infants died before their second birthday, as compared with a 1.6% and 5.6% mortality in HIV- and seroeverters. HIV+ infants with an average weight-for-age Z-score below -1.5 in the first year of life have a nearly fivefold risk of dying before 25 months of age compared with noninfected controls. CONCLUSION: Perinatally acquired HIV infection is associated with early and progressive growth failure. The severity of growth failure is associated with an increased risk of mortality. The effect of early, aggressive nutritional intervention in delaying HIV progression and mortality should be evaluated by controlled intervention studies.

UR - http://www.scopus.com/inward/record.url?scp=0031175292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031175292&partnerID=8YFLogxK

M3 - Article

C2 - 9200381

AN - SCOPUS:0031175292

VL - 100

SP - E7

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1

ER -